Although daily low - dose aspirin isn't for everyone, new research suggests that middle - aged
people on aspirin therapy may have as much as a 25 percent lower risk of developing colon cancer.
Not exact matches
On the basis of similar — though admittedly stronger — evidence, doctors already advise millions of
people to take low - dose
aspirin to reduce their risk of having heart attacks and strokes.
On average, most
people take in approximately 30 to 50 milligrams per day of aluminum from food; those using over-the-counter medications such as antacids and buffered
aspirins ingest larger amounts, roughly five grams a day.
A new study published in the prestigious Journal of the American Medical Association (JAMA) suggests the link between
aspirin and colon cancer prevention may depend
on a
person's individual genetics.
The findings should push more
people toward the AHA and USPSTF advice, which calls for
people to discuss with their doctor their individual risk and benefit ratio, rather than deciding that
aspirin is or isn't right for them based
on the drug's label.
Anti-clotting medications like
aspirin are often used to break up the blockage, but some
people require surgery, depending
on severity.
We're saying that
people are more likely to overdose
on aspirin and die than die from a pit bite.
Yet, how often do you hear of
people dying from taking
aspirin or from drowning in a bucket of water
on the news?
But painting this as the «normal», opinion - based sort of consensus is a good denial tactic, as is highlighting the views of the very few contrarian climate scientists (who are in the same boat as the
people who authored negative trials
on aspirin, if there are any - they're destined for the dustbin of science history.)